[Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride].
D000433:1-Propanol / Q000494:pharmacology; D000273:Adipose Tissue / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001892:Camphanes / Q000494:pharmacology; D003408:Cresols / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D001892:Camphanes; D003408:Cresols; D007004:Hypoglycemic Agents; D011437:Propylamines; D013453:Sulfonylurea Compounds; D000433:1-Propanol; D005990:Glycerol; D009638:Norepinephrine; D010646:Phentolamine
Extrapankreatische Wirkungen von Sulfonylharnstoffen. V. Untersuchungen zur antilipolytischen Eigenschaft von Glibornurid.